Sun, Y.; Geng, X.; Ma, Y.; Qin, Y.; Hu, S.; Xie, Y.; Wang, R.
Artificial Base-Directed In Vivo Formulation of Aptamer–Drug Conjugates with Albumin for Long Circulation and Targeted Delivery. Pharmaceutics 2022, 14, 2781.
https://doi.org/10.3390/pharmaceutics14122781
AMA Style
Sun Y, Geng X, Ma Y, Qin Y, Hu S, Xie Y, Wang R.
Artificial Base-Directed In Vivo Formulation of Aptamer–Drug Conjugates with Albumin for Long Circulation and Targeted Delivery. Pharmaceutics. 2022; 14(12):2781.
https://doi.org/10.3390/pharmaceutics14122781
Chicago/Turabian Style
Sun, Yang, Xinyao Geng, Yue Ma, Yu Qin, Shangjiu Hu, Yuquan Xie, and Ruowen Wang.
2022. "Artificial Base-Directed In Vivo Formulation of Aptamer–Drug Conjugates with Albumin for Long Circulation and Targeted Delivery" Pharmaceutics 14, no. 12: 2781.
https://doi.org/10.3390/pharmaceutics14122781
APA Style
Sun, Y., Geng, X., Ma, Y., Qin, Y., Hu, S., Xie, Y., & Wang, R.
(2022). Artificial Base-Directed In Vivo Formulation of Aptamer–Drug Conjugates with Albumin for Long Circulation and Targeted Delivery. Pharmaceutics, 14(12), 2781.
https://doi.org/10.3390/pharmaceutics14122781